The Seventh Annual Hematology Review conference will take place February 11, 2017 at the Huntsman Cancer Institute, and will feature keynote speaker Jerald Radich, MD, of the Fred Hutchinson Cancer Research Center.... Read MoreInternal Medicine
Division of Hematology & Hematologic Malignancies
The scientific focus of our division is the study of blood and bone marrow in health and disease. Our physicians treat patients with blood cancer, such as leukemias and lymphomas; clotting disorders, such as hemophilia; and diseases of iron metabolism, such as hemochromatosis. Starting with Maxwell Wintrobe, one of the founding fathers of Hematology and the University of Utah Medical School, our division can look back at a long-standing tradition of excellence in research, clinical care and teaching.
Last year researchers from our division garnered more than $7,000,000 in grant income, presented their data at major conferences, and published their results in prime international journals. This would not be possible without the University of Utah’s outstanding collaborative environment and its strong scientific foundation.
Congratulations to Hematology faculty and trainees who had delivered presentations at the December 2016 ASH meeting in San Diego CA. Drs. Halwani and Stephens presented their clinical trials research on lymphoma. Clinical Fellow Dr. Ami Patel presented a lecture entitled, "Oral-34: Stroma-Based Activation of pSTAT3Y705 Confers Resistance to FLT3 Inhibitors in FLT3 ITD-Positive AML". Two post-doctoral fellows in the laboratory of Drs. Deininger and O'Hare Dr. Anna Eiring and Dr. Dongqing Yan delivered presentations entitled, " Oral-34: Stroma-Based Activation of pSTAT3Y705 Confers Resistance to FLT3 Inhibitors in FLT3 ITD-Positive AML" and " Oral-636: Selective Inhibition of Nuclear Cytoplasmic Transport As a New Treatment Paradigm in Myelofibrosis", respectively. ... Read MoreInternal Medicine
Congratulations to Dr. Atanackovic for his receipt of the 2017 Brian Novis Senior Science award from the International Myeloma Foundation. His research focuses on immunotherapeutic approaches for multiple myeloma. ... Read MoreInternal Medicine